Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Squamous Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002695
What this trial is testing

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 530
Large-scale testing (Phase 3)Study completedNCT02785939
What this trial is testing

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Who this might be right for
CCND1 Gene AmplificationCCND2 Gene AmplificationCCND3 Gene Amplification+3 more
SWOG Cancer Research Network 53
Not applicableUnknownNCT06410677
What this trial is testing

Changhai Multimodal Esophageal Cancer Cohort

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wangluowei 110
Testing effectiveness (Phase 2)Study completedNCT00783705
What this trial is testing

Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Who this might be right for
Non-small Cell Lung CancerSquamous Lung Dysplasia
National Cancer Institute (NCI) 85
Large-scale testing (Phase 3)Ended earlyNCT00559351
What this trial is testing

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Who this might be right for
Esophageal NeoplasmsSquamous Cell Cancer
Ministry of Scientific Research and Information Technology, Poland 84
Early research (Phase 1)Study completedNCT04572100
What this trial is testing

Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
University of Chicago 50
Large-scale testing (Phase 3)Study completedNCT03833167
What this trial is testing

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Who this might be right for
Carcinoma, Squamous Cell
Merck Sharp & Dohme LLC 450
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Not applicableStudy completedNCT00004867
What this trial is testing

Positron Emission Tomography in Determining Stage of Esophageal Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 235
Testing effectiveness (Phase 2)UnknownNCT05541445
What this trial is testing

Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Not applicableUnknownNCT02497573
What this trial is testing

Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer?

Who this might be right for
Head and Neck Cancer
NHS Greater Glasgow and Clyde 80
Testing effectiveness (Phase 2)Ended earlyNCT02901483
What this trial is testing

PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
PharmaEngine 12
Large-scale testing (Phase 3)Looking for participantsNCT06737822
What this trial is testing

Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:

Who this might be right for
Oral CancerHead and Neck Neoplasms
All India Institute of Medical Sciences, Jodhpur 346
Testing effectiveness (Phase 2)Study completedNCT00550537
What this trial is testing

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT03726775
What this trial is testing

Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 61
Large-scale testing (Phase 3)Ended earlyNCT00198328
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head Neck Cancer
Inovio Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT00559156
What this trial is testing

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 46
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Early research (Phase 1)Study completedNCT04196283
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 30
Next Page